CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating YM060 for diarrhea-predominant irritable bowel syndrome in female patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED